Clinical Trial Update: Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos. [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing preserved vs preservative-free latanoprost 0.005% in primary open-angle glaucoma and ocular hypertension patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost 0.005% (latanoprost)
• latanoprost 0.005% (preservative-free) (latanoprost)
• latanoprost 0.005% (preserved) (latanoprost)

Snippet

Sponsor: Uzoma Chinyei Joan | Conditions: Effect of Drug | Phase 4 | Status: UNKNOWN